October 2022 - Page 6 of 22

MondayOct 24, 2022 1:00 pm

QualityStocksNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Distinctive with Ground-Breaking Research, Commitment to Developing Innovative Solutions

Silo Pharma (NASDAQ: SILO) recently uplisted to the NASDAQ after the exciting progress it made over the last year. “Silo Pharma announced that it had successfully priced its fully underwritten initial public offering, raising gross proceeds of $5 million through the sale of one million shares of common stock,” reads a recent article. “Originally founded in 2010, Silo Pharma has distinguished itself amongst peers for its ground-breaking research into conditions such as post-traumatic stress disorder (‘PTSD’), fibromyalgia, Alzheimer’s, Parkinson’s, and other rare neurological disorders. Increasingly and over the past two decades, clinical research on psychedelics, most notably psilocybin and methylenedioxymethamphetamine…

MondayOct 24, 2022 12:00 pm

REZYFi, Inc. Helps Cannabis-Related Businesses Succeed in California Through Alternative Finance Success

The global cannabis market is expected to reach $27.7 billion in 2022, growing at a CAGR of 24.3% through 2027, resulting in an anticipated value of $82.3 billion during the forecast period REZYFi is positioned as one of the first cannabis mortgage bankers in the United States, using its experience, independent network of brokers, and proprietary technology, to expand alternative financing options in the industry The company is currently licensed in 36 states with plans to expand in the future California began paving the way for cannabis-related businesses in 1996 when voters passed the Compassionate Use Act, legalizing the medicinal…

MondayOct 24, 2022 11:15 am

Modern Appeal of Backcountry Exploration Reflected by Enthusiastic Response to CubCrafters Inc.’s Buildup to Public Offering as a STOL-capable Aircraft Manufacturer

CubCrafters is an aircraft design and manufacturing company focused on supporting the independent exploration of backcountry locales with a variety of models in multiple aircraft certification classes The Washington-based company announced plans for a public offering of its stock this summer, now pending imminent qualification by the SEC The public funding of the company will give CubCrafters capital that it plans to use to accelerate the pace of fulfilling customer orders and increasing its service capabilities for existing clients The Reg A filing announced in July with a $50 million target offering attracted $5 million in reservations within just the…

MondayOct 24, 2022 10:55 am

QualityStocksNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Announces the I-GO(TM), a Fully EU Homologated Vehicle

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced that it has secured exclusive sales, distribution and branding rights to the new compact urban delivery electric vehicle, the I-GO, which is fully EU Standard homologated and certified for sale in select European markets. The I-GO bridges the gap between the growing demand for quick deliveries and space constraints found throughout the dense cities of Europe. “Securing the exclusive sales, distribution and branding rights in major European countries for a ready to market electric commercial delivery vehicle is a huge win for the company. The company plans on…

MondayOct 24, 2022 10:30 am

Silo Pharma Inc.’s (NASDAQ: SILO) Novel Ketamine Formulation Undergoing Safety Evaluation, Pursuing Regulatory Pathway

Ketamine used for decades in large doses for surgical anesthesia, low-dose treatments currently prescribed for pain relief, sedation, and treatment-resistant depression Silo’s time-released ketamine formulation SP-26 currently undergoing safety evaluation, study to uncover maximum tolerated dosing data for future trials SP-26 previously reported positive results in reducing neuropathic nerve pain Silo preparing FDA Pre-Investigational New Drug (“IND”) package for SP-26, intends to pursue 505(b)(2) regulatory pathway Ketamine was approved in the United States in 1970 and has been used extensively for surgical anesthesia. Since then, use of the drug in small doses has expanded considerably to treat pain and treatment-resistant…

MondayOct 24, 2022 10:24 am

QualityStocksNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Enters into Acquisition Agreement with German-Based Pharmaceutical, Medical Cannabis Distributor

Flora Growth (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, has inked a definitive agreement with Franchise Global Health Inc. (TSX.V: FGH), a multinational operator in the medical cannabis and pharmaceutical industry. The agreement outlines Flora Growth’s plans to acquire 100% of Franchise Global Health, which has principal operations in Germany, in an all-stock transaction. According to the agreement, the acquisition gives FLGC a foothold in German’s medical cannabis space because FGH’s German businesses service an estimated 1,200 pharmacies in the country; FGH also provides noncannabis medical products to 28 additional countries. In the first…

MondayOct 24, 2022 9:45 am

Cepton, Inc. (NASDAQ: CPTN) to Help Accelerate Advancement of Vehicle Autonomy; Collaborates with NVIDIA DRIVE Sim(TM) to Add Its Lidar Models into Simulation Platform for Autonomous Driving

Cepton announced a collaboration with NVIDIA, a cutting-edge platform for large-scale, accurate multi-sensor simulation for autonomous driving; developed sensor ecosystem is essential for AV development and validation in simulation NVIDIA DRIVE Sim(TM) allows users to test Cepton lidars and accelerate and scale deployment; Company expects to accelerate development of lidars for assisted and autonomous driving for global customers through this collaboration At the recent IAA Transportation 2022 conference, Cepton exhibited its Nova lidar integrated into a heavy-duty truck headlamp by ZKW Group GmbH “Lidar is essential to autonomous mobility, but deploying lidar at scale entails extensive testing and validation, sometimes…

MondayOct 24, 2022 9:00 am

Advanced Container Technologies Inc. (ACTX) Leaders Talk Game-Changing Microfarm Growing Option on Episode of Leading Podcast

ACTX CEO Doug Heldoorn, Grow Pod inventor Shannon Illingworth discuss the innovative microfarm option on recent Gamechangers LIVE podcast Discussion focuses on history of company, significant health and safety benefits of Grow Pods Company is dedicated to developing, manufacturing and selling advanced cultivation equipment and packaging systems Advanced Container Technologies (OTC: ACTX) chair and CEO Doug Heldoorn was a featured guest on a recent episode of the Gamechangers LIVE podcast (https://ibn.fm/hN87Z). Heldoorn was joined by Shannon Illingworth, inventor of Grow Pods, the microfarm containers that ACTX distributes throughout the United States. During the podcast, the two men discussed the origins…

FridayOct 21, 2022 3:42 pm

QualityStocksNewsBreaks – Cerberus Cyber Sentinel Corporation (NASDAQ: CISO) Featured in Equity Research Report

Cerberus Sentinel (NASDAQ: CISO), an industry leader as a managed cybersecurity and compliance provider based in Scottsdale, Arizona, was featured in a recent equity research report published by Cantor Fitzgerald titled “Strong Vision and M&A Execution Playbook Position to Address Cyberattacks, Cybersecurity Talent Shortages; Launching Coverage at OW with a $5 PT.” The publication reads, “Growth Strategy Focused on Acquisitions and Organic Expansion. Cerberus Sentinel intends to capitalize on the growing ‘achievement gap’ between increased risk and exposure to cyber threats and the decreasing pool of resources available to address this risk as its core growth opportunity. The majority of…

FridayOct 21, 2022 3:16 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM) Holds Potential to Represent Multiple Commercial Opportunities

Lexaria Bioscience Corp. (NASDAQ: LEXX), a drug delivery platform innovator, last year announced a review of its successful 2021 antiviral drug program. “Lexaria specifically probed the bioavailability of five DehydraTECH(TM)-processed antiviral drugs for SARS-CoV-2, HIV/AIDS and other infectious diseases from three drug classes, evidencing significant gains with up to a three-fold increase in oral drug delivery into the bloodstream. The demonstrated improvements in absorption, Lexaria believed, could have significant commercial potential considering that many antiviral drugs typically show low oral bioavailability in their available form because of significant liver biotransformation and/or poor intestinal uptake,” reads a recent article. “Lexaria’s vision…

Site Search

Company Search

Month: October 2022